FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/11/2024
Back to search
Official data from USPTO
PHINDER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
08/11/2024
Trademark type
Combined
Nice classes
5, 10, 44
Filing date
04/11/2022
Registration date
03/12/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/12/2024
Last transaction
03/12/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
24
Owner location
SG
Examiner
HARMON, RAYMOND E
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MIRXES PTE. LTD.
Representatives
Joseph G. Chu JCIP
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical and veterinary use or purposes; reactants for medical and veterinary diagnosisreagents for medical use; diagnostic preparations for medical use for sale in kit form; diagnostic products for medical purposesmedical diagnostic reagents; indicators for medical diagnosismedical diagnostic reagents; veterinary diagnostic reagents; reagents in kit form for conducting Real Time Polymerase Chain Reaction assays (RT-PCR) for medical or veterinary purposes; reagents for medical or veterinary purposes; reagents for use in diagnostic tests for medical or veterinary purposes; medical diagnostic reagents for testing of body fluids; stem cells for medical and veterinary purposes; substances for use in genetic probe assay kits for medical usereagents for use in medical testing; preparations for medical diagnostic use; biochemical diagnostic preparations for medical diagnostic use; products for medical diagnosismedical diagnostic reagents; diagnostic agents for pharmaceutical use; test reagents for medical diagnosis; diagnostic biomarker reagents for medical purposes; chemical preparations for diagnostic purposes; chemical preparations for use in RNA and DNA analysisreagents for use in medical testing; chemical products for medical analysisreagents for use in medical testing; preparations for detecting genetic predispositions for medical purposes; reagents for medical analytical purposes; synthetic deoxyribonucleic acid and synthetic ribonucleic acid for medical use; nucleic acid amplification reagents for medical use
Class 10
Medical diagnostic apparatusmedical diagnostic apparatus for detecting pulmonary hypertension; medical diagnostic instrumentsmedical diagnostic apparatus for detecting pulmonary hypertension; biomedical testing apparatusapparatus for DNA and RNA testing for medical purposes; tools for medical diagnosticsapparatus for DNA and RNA testing for medical purposes; medical instruments for infectious disease testing; testing apparatus for sale in kit form for medical diagnostic purposesapparatus for DNA and RNA testing for medical purposes; medical diagnostic testing apparatusapparatus for DNA and RNA testing for medical purposes; in-vitro diagnostic testing apparatus for medical useapparatus for DNA and RNA testing for medical purposes; diagnostic testing apparatus for use in molecular diagnostic procedures for medical purposesapparatus for DNA and RNA testing for medical purposes; apparatus for blood tests for medical use
Class 44
Medical diagnostic servicesmedical diagnostic testingmonitoring and reporting services; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for the diagnosis of cancer; genetic testing for medical purposesRNA and DNA analysis for pulmonary hypertension diagnosis and prognosis; performing diagnosis of diseases; medical analysis services for the diagnosis of conditions of the human body; medical laboratory services related to the treatment of patientsmedical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis for the diagnosis and treatment of persons; health assessment services by means of conducting health risk assessment surveys; health-care services; genetic testing for medical purposes; genetic testingRNA and DNA screening for medical purposes; medical analysis services for the diagnosis of pulmonary hypertension; medical screening; medical screeninghealth screening
Publications
History of USPTO decisions and trademark events.
28 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/18/2024
FIMP
FINAL DISPOSITION PROCESSED
07/18/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/13/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
03/12/2024
GPNX
NOTIFICATION PROCESSED BY IB
12/26/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/26/2023
PUBO
PUBLISHED FOR OPPOSITION
12/26/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/06/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/06/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/22/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/17/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/28/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/28/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/28/2023
RFNT
REFUSAL PROCESSED BY IB
04/19/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/30/2023
RFRR
REFUSAL PROCESSED BY MPU
03/30/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/08/2023
CNRT
NON-FINAL ACTION WRITTEN
02/07/2023
DOCK
ASSIGNED TO EXAMINER
01/27/2023
MAFR
APPLICATION FILING RECEIPT MAILED
06/21/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/17/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/16/2022
Continuous trademark protection
Get notified about every new filing that threatens PHINDER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.